Dr. Martens plc (LON:DOCS - Get Free Report) was down 1.2% on Thursday . The company traded as low as GBX 54.35 ($0.71) and last traded at GBX 54.60 ($0.71). Approximately 2,147,780 shares changed hands during trading, an increase of 0% from the average daily volume of 2,145,799 shares. The stock had previously closed at GBX 55.25 ($0.72).
Dr. Martens Trading Up 1.2 %
The company has a market capitalization of £531.35 million, a P/E ratio of 789.29, a PEG ratio of 6.40 and a beta of 0.11. The business's 50-day moving average price is GBX 63.41 and its two-hundred day moving average price is GBX 73.60. The company has a debt-to-equity ratio of 129.55, a current ratio of 2.85 and a quick ratio of 1.13.
Insider Activity at Dr. Martens
In related news, insider Andrew Harrison acquired 58,220 shares of the business's stock in a transaction that occurred on Tuesday, September 24th. The shares were acquired at an average cost of GBX 52 ($0.68) per share, with a total value of £30,274.40 ($39,533.04). In related news, insider Andrew Harrison acquired 58,220 shares of the business's stock in a transaction that occurred on Tuesday, September 24th. The shares were acquired at an average cost of GBX 52 ($0.68) per share, with a total value of £30,274.40 ($39,533.04). Also, insider Kenny Wilson purchased 30,000 shares of the stock in a transaction on Thursday, September 26th. The stock was acquired at an average price of GBX 55 ($0.72) per share, for a total transaction of £16,500 ($21,546.10). In the last ninety days, insiders have purchased 113,446 shares of company stock valued at $6,542,582. 4.36% of the stock is owned by corporate insiders.
About Dr. Martens
(
Get Free Report)
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It offers originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
Featured Articles
Before you consider Dr. Martens, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Dr. Martens wasn't on the list.
While Dr. Martens currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
